A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions
about
Angiogenesis in urological malignancy: prognostic indicator and therapeutic target.Current status of antiangiogenic factors.Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.Anti-angiogenic therapies in cancer clinical trials.Anti-angiogenic drugs: from bench to clinical trials.Heparanase: a target for drug discovery in cancer and inflammation.Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactiNew constituents from Crinum latifolium with inhibitory effects against tube-like formation of human umbilical venous endothelial cells.Breast cancer angiogenesis--new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting.Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.Suramin inhibits C6 glioma-induced angiogenesis in vitro.The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.Suramin and suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum.The effect of suramin on the resorption of bovine nasal cartilage.Revisiting Multiple-Instance Learning Via Embedded Instance Selection
P2860
Q33598141-515F7E39-725D-4AF9-BF32-937769CA72EAQ33962049-B5A9779F-83B7-4BEF-A02B-E2CAC40481A9Q34792865-D04A6324-92BB-46E0-A6DD-8041A25FA221Q36181120-C5CD25EB-D6F0-4B54-AB99-BE118AB07AF7Q36465476-17A5F30B-A299-4BA0-A487-A9E7EB60E608Q36752653-723ED8D6-B7EC-462D-801B-7AA528C763C0Q38353450-CD03E90B-592B-4A68-93FA-364CBFBFEB61Q40206704-E9062DCF-CFBD-4D9A-B586-CAE911E2A529Q40481477-733A0A99-FBB5-4D8D-998A-200EE42C7A93Q40958050-7B73E7AB-FD93-4C78-936A-18FE4E1D8127Q41140293-F93196BF-5039-4D1D-955C-7460CA712732Q41342332-546CC1CA-4EE6-4E64-98A8-E8BD9D78E698Q43822559-0DBFBCB7-8A47-43D8-AA1F-4B0FDF2DA0E4Q44588579-13E9F69F-7C55-4716-8158-0516B633E437Q50466738-2F13EE08-C92C-4AC0-9F04-E328C897D3B2Q58561173-28A9CC85-B441-44D0-906B-268343B12C40
P2860
A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
A structure-activity analysis ...... suramin and related polyanions
@ast
A structure-activity analysis ...... suramin and related polyanions
@en
type
label
A structure-activity analysis ...... suramin and related polyanions
@ast
A structure-activity analysis ...... suramin and related polyanions
@en
prefLabel
A structure-activity analysis ...... suramin and related polyanions
@ast
A structure-activity analysis ...... suramin and related polyanions
@en
P2093
P2860
P356
P1476
A structure-activity analysis ...... suramin and related polyanions
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1994.172
P407
P577
1994-05-01T00:00:00Z